Studies have demonstrated that IL-6 is involved in NASH progression through the IL-6/signal transducer and activator of transcription 3 (STAT3) signaling pathway (Cai et al., 2016; Li et al., 2022). The gene discussed is STAT3; the disease is metabolic dysfunction-associated steatohepatitis.